7c1ad1a3 194b 4c50 Bd5e Ebf80ae568ae 01
Potassium Citrate Tablet, Extended Release
Product Images NDC 68382-538
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 68382-538). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
7c1ad1a3 194b 4c50 Bd5e Ebf80ae568ae 02
The given text is a description of a medicine called "Potassium Citrate Extended-release Tablets USP". The tablets contain 5 mEq of potassium citrate and are used to treat certain medical conditions. Each tablet is tan to yellowish in color, round-shaped, and biconvex. The tablets should be stored at 20°C to 25°C and dispensed in a tight container. The dosage should be as per the package insert for complete prescribing information. The given description also contains the manufacturer and the importer names, along with other important details for pharmacists.*
7c1ad1a3 194b 4c50 Bd5e Ebf80ae568ae 03
This is a label for a medicine called Potassium Citrate Extended-release Tablets USP. The tablet contains 10mEq of potassium citrate and is oval shaped and uncoated. The tablet is tan to yellowish in color and is debossed with the number "537" on one side. The label provides information on dosage, storage, and dispensing. The drug should be kept out of the reach of children. The label also includes information on the manufacturer and distributor.*
7c1ad1a3 194b 4c50 Bd5e Ebf80ae568ae 04
This is a product description for Potassium Citrate Extended-release Tablets USP, a medication used to treat kidney stones. The tablets come in a 15 mEq dosage and are tan to yellow in color. They are uncoated, oblong-shaped, and biconvex. The package insert provides complete prescribing information, including dosage recommendations. The tablets need to be stored in a tight container at a temperature between 20 to 25°C. The package is manufactured by Cadila Healthcare Ltd. in Baddi, India, and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
